Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Trajan Group Holdings Ltd ( (AU:TRJ) ).
Trajan Group Holdings Limited announced that Sara Watts, Non-executive Director and Chair of the Audit and Risk Committee, will retire from the Board and not seek re-election at the 2025 Annual General Meeting. Her departure marks the end of her tenure since joining the Board in March 2021, just before the company’s IPO. Tiffiny Lewin will take over as Chair of the Audit and Risk Committee. This change in leadership may impact the company’s governance and strategic direction as it continues to focus on using science and medical technology to improve human wellbeing.
The most recent analyst rating on (AU:TRJ) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
More about Trajan Group Holdings Ltd
Trajan Group Holdings Limited is a global developer and manufacturer of analytical and life sciences products and devices. The company focuses on enabling science that benefits people by enhancing personal health through scientific tools and solutions. Trajan’s products are utilized in the analysis of biological, food, and environmental samples, with a portfolio supporting the shift towards decentralized, personalized data-based healthcare. The company operates with over 600 employees across seven manufacturing sites in the US, Australia, Europe, and Malaysia, with operations spanning Australia, the US, Asia, and Europe.
Average Trading Volume: 39,703
Technical Sentiment Signal: Sell
Current Market Cap: A$128M
See more insights into TRJ stock on TipRanks’ Stock Analysis page.